We are live on !
Find out more
EntryPoint Capital Portfolio holdings
AUM
$412M
Turnover
50.4%
1-Year Est. Return
28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$70.8M
(+21%)
Cap. Flow
+$36.5M
Cap. Flow % of AUM
Cap. Flow %
8.87%
Top 10 Holdings %
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234
Avg Time Held
0.4
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$1.67M |
| 2 |
Donaldson
DCI
|
+$1.6M |
| 3 |
FedEx
FDX
|
+$1.6M |
| 4 |
Fidelity National Financial
FNF
|
+$1.53M |
| 5 |
Graco
GGG
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$1.48M |
| 2 |
TIC Solutions Inc
TIC
|
+$1.48M |
| 3 |
Schrodinger
SDGR
|
+$1.27M |
| 4 |
Exelon
EXC
|
+$1.23M |
| 5 |
Visteon
VC
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18% |
| 2 | Financials | 16.8% |
| 3 | Healthcare | 15.07% |
| 4 | Technology | 12.86% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
Neurocrine Biosciences
NBIX
$14.5B
| – | – |
-6,704
| Closed | -$883K | – |
|
902
Nabors Industries
NBR
$1.22B
| – | – |
-2,735
| Closed | -$235K | – |
|
903
Vitamin Cottage Natural Grocers
NGVC
$674M
| – | – |
-13,846
| Closed | -$358K | – |
|
904
Neumora Therapeutics
NMRA
$89.2M
| – | – |
-110,875
| Closed | -$216K | – |
|
905
Newmark Group
NMRK
$2.12B
| – | – |
-19,963
| Closed | -$299K | – |
|
906
Northrop Grumman
NOC
$77.2B
| – | – |
-1,145
| Closed | -$781K | – |
|
907
NOV
NOV
$6.82B
| – | – |
-13,534
| Closed | -$255K | – |
|
908
NRG Energy
NRG
$21B
| – | – |
-5,267
| Closed | -$770K | – |
|
909
Old Dominion Freight Line
ODFL
$39.1B
| – | – |
-3,114
| Closed | -$608K | – |
|
910
Organon & Co
OGN
$3.62B
| – | – |
-15,231
| Closed | -$91.2K | – |
|
911
Opko Health
OPK
$1.22B
| – | – |
-342,171
| Closed | -$390K | – |
|
912
Ormat Technologies
ORA
$5.53B
| – | – |
-2,265
| Closed | -$253K | – |
|
913
OneSpaWorld
OSW
$2.43B
| – | – |
-41,714
| Closed | -$957K | – |
|
914
Blue Owl Capital
OWL
$6.33B
| – | – |
-12,275
| Closed | -$112K | – |
|
915
Ranpak Holdings
PACK
$292M
| – | – |
-20,621
| Closed | -$73.6K | – |
|
916
Penske Automotive Group
PAG
$13.9B
| – | – |
-3,367
| Closed | -$503K | – |
|
917
Prosperity Bancshares
PB
$8.23B
| – | – |
-6,565
| Closed | -$441K | – |
|
918
Procore
PCOR
$9.28B
| – | – |
-6,879
| Closed | -$392K | – |
|
919
Pacira BioSciences
PCRX
$1.45B
| – | – |
-21,268
| Closed | -$481K | – |
|
920
Paylocity
PCTY
$8.99B
| – | – |
-6,136
| Closed | -$663K | – |
|
921
Pegasystems
PEGA
$5.75B
| – | – |
-8,588
| Closed | -$366K | – |
|
922
Progressive
PGR
$129B
| – | – |
-4,197
| Closed | -$832K | – |
|
923
Parker-Hannifin
PH
$120B
| – | – |
-553
| Closed | -$495K | – |
|
924
Polaris
PII
$3.07B
| – | – |
-3,691
| Closed | -$201K | – |
|
925
Philip Morris
PM
$303B
| – | – |
-2,664
| Closed | -$440K | – |
|
Similar funds
EntryPoint Capital's Q2 2026 Portfolio in Review
As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.
- EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
- EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
- EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
- EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
- EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
- EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
- EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.